These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 28422425)

  • 21. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
    Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
    Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Pomposelli JJ; Goodrich NP; Emond JC; Humar A; Baker TB; Grant DR; Fisher RA; Roberts JP; Olthoff KM; Gillespie BW; Merion RM
    Transplantation; 2016 Jul; 100(7):1490-9. PubMed ID: 27326811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who fares worse after liver transplantation? Impact of donor and recipient variables on outcome: data from a prospective study.
    Gambato M; Frigo AC; Rodríguez Castro KI; Senzolo M; Nadal E; D'Amico F; Vitale A; Gringeri E; Zanus G; Cillo U; Russo FP; Burra P
    Transplantation; 2013 Jun; 95(12):1528-34. PubMed ID: 23722633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers.
    Benko T; Gallinat A; Minor T; Saner FH; Sotiropoulos GC; Paul A; Hoyer DP
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):716-722. PubMed ID: 28441690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care.
    Bohorquez H; Bugeaud E; Bzowej N; Scheuermann J; Hand J; Bruce D; Carmody I; Cohen A; Joshi S; Seal J; Sonnier D; Therapondos G; Girgrah N; Anders S; Loss GE
    Liver Transpl; 2021 Apr; 27(4):548-557. PubMed ID: 33098277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.
    Salvalaggio PR; Felga GE; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2449-51. PubMed ID: 23026617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
    Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
    Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
    Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of hepatitis C-related liver transplantation in direct-acting antiviral era.
    Choudhary NS; Saraf N; Saigal S; Rastogi A; Bhangui P; Thiagrajan S; Soin AS
    Indian J Gastroenterol; 2020 Dec; 39(6):539-543. PubMed ID: 33230754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
    Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
    Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
    Yunhua T; Weiqiang J; Maogen C; Sai Y; Zhiheng Z; Dongping W; Zhiyong G; Xiaoshun H
    J Clin Monit Comput; 2018 Jun; 32(3):471-479. PubMed ID: 28831767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.
    Chhatwal J; Samur S; Bethea ED; Ayer T; Kanwal F; Hur C; Roberts MS; Terrault N; Chung RT
    Hepatology; 2018 Jun; 67(6):2085-2095. PubMed ID: 29222916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients.
    Ferri F; Lai Q; Molinaro A; Poli E; Parlati L; Lattanzi B; Mennini G; Melandro F; Pugliese F; Maldarelli F; Corsi A; Riminucci M; Merli M; Rossi M; Ginanni Corradini S
    Can J Gastroenterol Hepatol; 2019; 2019():5862985. PubMed ID: 31187028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A score model for the continuous grading of early allograft dysfunction severity.
    Pareja E; Cortes M; Hervás D; Mir J; Valdivieso A; Castell JV; Lahoz A
    Liver Transpl; 2015 Jan; 21(1):38-46. PubMed ID: 25204890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
    Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
    World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.
    Shaffer AA; Thomas AG; Bowring MG; Van Pilsum Rasmussen SE; Cash A; Kucirka LM; Alqahtani SA; Gurakar A; Sulkowski MS; Cameron AM; Segev DL; Durand CM
    Transpl Infect Dis; 2018 Dec; 20(6):e12982. PubMed ID: 30144258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.